What We're Reading: Page 405

Industry reads hand-picked by our editors

Jul 11, 2014

Pharma Times
Are investors feeling more love for pharma?
The New York Times
Suddenly, some cheap generics aren't so cheap

Jul 10, 2014

Pharma Times
Are investors feeling more love for pharma?

Jul 09, 2014

The New York Times
Hedge fund nominates Allergan slate as takeover fight escalates

Jul 08, 2014

WSJ
Valeant may have antidote for Allergan's 'poison pill'
biospace.com
FDA puts government-funded ebola study on clinical hold
WSJ
J&J's DePuy Synthes cuts 400 existing jobs, creates 80 new jobs
pharmafile.com
Spectrum does it again, gains approval for another lymphoma drug

Jul 07, 2014

To find more content, use the "Topics" in the menu above.

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Are investors feeling more love for pharma?

Suddenly, some cheap generics aren't so cheap

Are investors feeling more love for pharma?

Hedge fund nominates Allergan slate as takeover fight escalates

Valeant may have antidote for Allergan's 'poison pill'

FDA puts government-funded ebola study on clinical hold

J&J's DePuy Synthes cuts 400 existing jobs, creates 80 new jobs

Spectrum does it again, gains approval for another lymphoma drug

Reach our audience

Related Publications

Don't miss tomorrow's biopharma industry news

What We're Reading: Page 405

Jul 11, 2014

Jul 10, 2014

Jul 09, 2014

Jul 08, 2014

Jul 07, 2014